Product
Glucose-dependent insulinotropic polypeptide
1 clinical trial
2 indications
Indication
Type 2 DiabetesIndication
ObesityClinical trial
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients With Type 2 DiabetesStatus: Recruiting, Estimated PCD: 2024-12-01